
INO
Inovio Pharmaceuticals, Inc.
$1.95
Open: $1.92 High: $1.95 Low: $1.85 Close: $1.92
Range: 2022-06-23 - 2022-06-24
Volume:1,028,779Market: Closed
Powered by Finage Stock APIDelayed data
INO
Inovio Pharmaceuticals, Inc. 6769 MESA RIDGE RD. https://www.inovio.com
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.- CEO: J. Joseph Kim
- Employees: 317
- Sector: Healthcare
- Industry: Biotechnology
INO News
Latest news about the INO
- Inovio to discontinue COVID vaccine trial, appoints Jacqueline Shea as CEO by Reuters at 5/10/22, 11:04 PMView More →
- 7 F-Rated Penny Stocks Not Worth the Gamble
It’s a new market, and not every bargain is an opportunity to jump in.
by Investor Place at 4/26/22, 12:00 AMView More → - Inovio lab tests show COVID vaccine weaker against Omicron, trial enrollment paused by Reuters at 3/1/22, 10:48 PMView More →
- Inovio says COVID vaccine shows robust T-cell response against Omicron in lab tests by Reuters at 3/1/22, 9:20 PMView More →